In Vitro & In Vivo Diagnostic Substances
15 stocks in Healthcare & Pharma · SIC 2835.
Company snapshot 2026-11-13 · Calculated market cap as of 2026-11-06 · USD
| Ticker | Company | Market Cap | Revenue (TTM) | Net Income (TTM) |
|---|---|---|---|---|
| IDXX | IDEXX LABORATORIES INC /DE | $52.84B | $4.66BTTM ended 2026-09-30 | $1.18BTTM ended 2026-09-30 |
| LNTH | Lantheus Holdings, Inc. | $6.59B | $1.56BTTM ended 2026-09-30 | $269.90MTTM ended 2026-09-30 |
| NEOG | NEOGEN CORP | $2.55B | $884.00MTTM ended 2026-08-31 | −$56.10MTTM ended 2026-08-31 |
| CLDX | Celldex Therapeutics, Inc. | $2.22B | $158.00KTTM ended 2026-09-30 | −$309.06MTTM ended 2026-09-30 |
| NTLA | Intellia Therapeutics, Inc. | $1.56B | $52.89MTTM ended 2026-09-30 | −$426.14MTTM ended 2026-09-30 |
| QDEL | QuidelOrtho Corp | $880.99M | $2.59BTTM ended 2026-09-27 | −$369.20MTTM ended 2026-09-27 |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | $656.00M | — | −$114.04MTTM ended 2026-06-30 |
| MYGN | MYRIAD GENETICS INC | $601.64M | $803.60MTTM ended 2026-09-30 | −$129.10MTTM ended 2026-09-30 |
| TKNO | Alpha Teknova, Inc. | $495.68M | $45.95MTTM ended 2026-09-30 | −$15.97MTTM ended 2026-09-30 |
| ICCC | IMMUCELL CORP /DE/ | $90.37M | $30.68MTTM ended 2026-06-30 | $787.37KTTM ended 2026-06-30 |
| IMDX | Insight Molecular Diagnostics Inc. | $80.50M | $1.67MTTM ended 2026-06-30 | −$49.36MTTM ended 2026-06-30 |
| BMRA | BIOMERICA INC | $7.40M | $4.34MTTM ended 2026-08-31 | −$5.01MTTM ended 2026-08-31 |
| CDIO | Cardio Diagnostics Holdings, Inc. | $4.96M | $15.19KTTM ended 2026-09-30 | −$6.49MTTM ended 2026-09-30 |
| QCLS | Q/C TECHNOLOGIES, INC. | $2.71M | — | −$16.57MTTM ended 2026-06-30 |
| VNRX | VOLITIONRX LTD | $2.59M | $2.46MTTM ended 2026-06-30 | −$25.64MTTM ended 2026-06-30 |
No matching companies.